Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia

Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia

(2013) S Kurosawa et al.   BONE MARROW TRANSPLANTATION

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

(2013) John Koreth et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry

(2012) S Kurosawa et al.   BONE MARROW TRANSPLANTATION

Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group

(2012) Shuichi Miyawaki   INTERNATIONAL JOURNAL OF HEMATOLOGY

Measuring Health-Related Quality of Life in Leukemia: The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire

(2012) David Cella et al.   VALUE IN HEALTH

A Prospective Study Comparing the Outcomes and Health-Related Quality of Life in Adult Patients with Myeloid Malignancies Undergoing Allogeneic Transplantation Using Myeloablative or Reduced-Intensity Conditioning

(2011) Vikas Gupta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

(2011) J. Pidala et al.   BLOOD

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

(2011) John T. Horan et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

(2011) John R. Wingard et al.   JOURNAL OF CLINICAL ONCOLOGY

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

(2010) S. Kurosawa et al.   BLOOD

Validation testing of a three-component model of Short Form-36 scores

(2010) Yoshimi Suzukamo et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

(2010) Paul J. Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation

(2009) Joseph Pidala et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Quality of life after allogeneic hematopoietic cell transplantation

(2009) J. Pidala et al.   BLOOD

Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention

(2009) Joseph Pidala et al.   BRITISH JOURNAL OF HAEMATOLOGY

The minimal detectable change cannot reliably replace the minimal important difference

(2009) Dan Turner et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

(2009) Bob Löwenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia

(2008) D. Messerer et al.   HAEMATOLOGICA